Prasterone
Indication
Vulvovaginal or vaginal atrophy in postmenopausal women having moderate to severe symptoms
Black
Brand:
Intrarosa®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Genito-urinary system
Background
Prasterone was only compared to placebo in clinical studies which makes comparison with currently used treatments for vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms difficult.
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: